期刊文献+

中医药治疗肝硬化腹水的研究进展

Research Progress of Traditional Chinese Medicine in the Treatment of Ascites in Liver Cirrhosis
下载PDF
导出
摘要 腹水是肝硬化失代偿期的严重并发症之一,其五年生存率仅为56%,严重威胁到患者的生命健康。西医治疗手段较为单调,且通常有较大的副作用。中医治疗手段则更为多样化、个体化,较之西医可以更加有效改善症状,减轻痛苦。本篇从中医内治以及外治两方面论述治疗肝硬化腹水的研究进展。 Ascites is one of the serious complications of decompensated liver cirrhosis, and its five-year sur-vival rate is only 56%, which seriously threatens the life and health of patients. Western medicine treatment is monotonous and usually has large side effects. TCM treatment methods are more di-versified and individualized, which can be more effective than Western medicine in improving symptoms and reducing suffering. This paper discusses the research progress in the treatment of ascites in liver cirrhosis from the aspects of internal and external treatment of traditional Chinese medicine.
作者 柳镕 费新应
出处 《中医学》 2023年第11期3216-3221,共6页 Traditional Chinese Medicine
  • 相关文献

参考文献36

二级参考文献588

共引文献235

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部